{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:00:43Z","timestamp":1755223243507,"version":"3.43.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,11]]},"DOI":"10.7759\/cureus.89801","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:26:37Z","timestamp":1754918797000},"source":"Crossref","is-referenced-by-count":0,"title":["Tropomyosin Isoforms as Biomarkers for Urothelial Bladder Cancer: Promise and Challenges"],"prefix":"10.7759","author":[{"given":"Daniel","family":"Akintelure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelumi","family":"Tawose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Akintelure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Agada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92033-5","article-title":"Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the Global Burden of Disease study 2021","volume":"15","author":"Su X","year":"2025","unstructured":"Su X, Tao Y, Chen F, Han X, Xue L. Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the Global Burden of Disease study 2021. Sci Rep. 2025, 15:7655. 10.1038\/s41598-025-92033-5","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2022.100663","article-title":"Challenges and opportunities in the management of non-urothelial bladder cancers","volume":"34","author":"Brown JT","year":"2023","unstructured":"Brown JT, Narayan VM, Joshi SS, Harik L, Jani AB, Bilen MA. Challenges and opportunities in the management of non-urothelial bladder cancers. Cancer Treat Res Commun. 2023, 34:100663. 10.1016\/j.ctarc.2022.100663","journal-title":"Cancer Treat Res Commun"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7150\/jca.28989","article-title":"A review on the accuracy of bladder cancer detection methods","volume":"10","author":"Zhu CZ","year":"2019","unstructured":"Zhu CZ, Ting HN, Ng KH, Ong TA. A review on the accuracy of bladder cancer detection methods. J Cancer. 2019, 10:4038-44. 10.7150\/jca.28989","journal-title":"J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051102","article-title":"Tropomyosins: potential biomarkers for urothelial bladder cancer","volume":"20","author":"Humayun-Zakaria N","year":"2019","unstructured":"Humayun-Zakaria N, Arnold R, Goel A, Ward D, Savill S, Bryan RT. Tropomyosins: potential biomarkers for urothelial bladder cancer. Int J Mol Sci. 2019, 20:1102. 10.3390\/ijms20051102","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1453278","article-title":"Bladder cancer biomarkers: current approaches and future directions","volume":"14","author":"Ahangar M","year":"2024","unstructured":"Ahangar M, Mahjoubi F, Mowla SJ. Bladder cancer biomarkers: current approaches and future directions. Front Oncol. 2024, 14:1453278. 10.3389\/fonc.2024.1453278","journal-title":"Front Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4161\/bioa.25616","article-title":"Periodicities designed in the tropomyosin sequence and structure define its functions","volume":"3","author":"Barua B","year":"2013","unstructured":"Barua B. Periodicities designed in the tropomyosin sequence and structure define its functions. Bioarchitecture. 2013, 3:51-6. 10.4161\/bioa.25616","journal-title":"Bioarchitecture"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713295","article-title":"Research advances in the role of the tropomyosin family in cancer","volume":"24","author":"Meng Y","year":"2023","unstructured":"Meng Y, Huang K, Shi M, Huo Y, Han L, Liu B, Li Y. Research advances in the role of the tropomyosin family in cancer. Int J Mol Sci. 2023, 24:13295. 10.3390\/ijms241713295","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2024.2358818","article-title":"Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update","volume":"34","author":"Iliev P","year":"2024","unstructured":"Iliev P, Jaworski C, W\u00e4ngler C, W\u00e4ngler B, Page BD, Schirrmacher R, Bailey JJ. Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update. Expert Opin Ther Pat. 2024, 34:231-44. 10.1080\/13543776.2024.2358818","journal-title":"Expert Opin Ther Pat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.11.21256306","article-title":"Exploring the extracellular transcriptome in seminal plasma for non-invasive prostate cancer diagnosis [PREPRINT]","volume":"0","author":"Hulstaert E","year":"2021","unstructured":"Hulstaert E, Morlion A, Nuytens J, et al.. Exploring the extracellular transcriptome in seminal plasma for non-invasive prostate cancer diagnosis [PREPRINT]. medRxiv. 2021, 0:0. 10.1101\/2021.05.11.21256306","journal-title":"medRxiv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6936262","article-title":"Tropomyosin is potential markers for the diagnosis and prognosis of bladder cancer","volume":"2022","author":"Yan Y","year":"2022","unstructured":"Yan Y, Li J, Ye M, Li Z, Li S. Tropomyosin is potential markers for the diagnosis and prognosis of bladder cancer. Dis Markers. 2022, 2022:6936262. 10.1155\/2022\/6936262","journal-title":"Dis Markers"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.162","article-title":"Expression of tropomyosin isoforms in benign and malignant human breast lesions","volume":"73","author":"Franz\u00e9n B","year":"1996","unstructured":"Franz\u00e9n B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H, Auer G. Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer. 1996, 73:909-13. 10.1038\/bjc.1996.162","journal-title":"Br J Cancer"},{"key":"ref12","unstructured":"In vivo disruption of Rb-E2F-Ezh2 signaling loop causes bladder cancer development. (2019). Accessed. August 10, 2025: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE38264."},{"key":"ref13","unstructured":"Molecular biomarker signature for bladder cancer detection. (2019). Accessed. August 10, 2025: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE31189."},{"key":"ref14","unstructured":"Predictive value of prognosis-related gene expression study in primary bladder cancer. (2020). Accessed. August 10, 2025: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE13507."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/11772719231190218","article-title":"The latest developments in using proteomic biomarkers from urine and serum for non-invasive disease diagnosis and prognosis","volume":"18","author":"Shama A","year":"2023","unstructured":"Shama A, Soni T, Jawanda IK, Upadhyay G, Sharma A, Prabha V. The latest developments in using proteomic biomarkers from urine and serum for non-invasive disease diagnosis and prognosis. Biomark Insights. 2023, 18:11772719231190218. 10.1177\/11772719231190218","journal-title":"Biomark Insights"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1145","article-title":"Epigenetic silencing of tropomyosin alters transforming growth factor beta control of cell invasion and metastasis","volume":"7","author":"Bakin A","year":"2005","unstructured":"Bakin A, Varga A, Zheng Q, Safina A. Epigenetic silencing of tropomyosin alters transforming growth factor beta control of cell invasion and metastasis. Breast Cancer Res. 2005, 7:P4.15. 10.1186\/bcr1145","journal-title":"Breast Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22556","article-title":"Measuring health-related quality of life outcomes in bladder cancer patients using the bladder cancer index (BCI)","volume":"109","author":"Gilbert SM","year":"2007","unstructured":"Gilbert SM, Wood DP, Dunn RL, Weizer AZ, Lee CT, Montie JE, Wei JT. Measuring health-related quality of life outcomes in bladder cancer patients using the bladder cancer index (BCI). Cancer. 2007, 109:1756-62. 10.1002\/cncr.22556","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-024-09462-z","article-title":"Recent progress in mass spectrometry-based urinary proteomics","volume":"21","author":"Joshi N","year":"2024","unstructured":"Joshi N, Garapati K, Ghose V, Kandasamy RK, Pandey A. Recent progress in mass spectrometry-based urinary proteomics. Clin Proteomics. 2024, 21:14. 10.1186\/s12014-024-09462-z","journal-title":"Clin Proteomics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000087792","article-title":"Non-invasive diagnostic tests for bladder cancer: a review of the literature","volume":"75","author":"Bassi P","year":"2005","unstructured":"Bassi P, De Marco V, De Lisa A, Mancini M, Pinto F, Bertoloni R, Longo F. Non-invasive diagnostic tests for bladder cancer: a review of the literature. Urol Int. 2005, 75:193-200. 10.1159\/000087792","journal-title":"Urol Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105141","article-title":"Structural and functional peculiarities of cytoplasmic tropomyosin isoforms, the products of TPM1 and TPM4 genes","volume":"22","author":"Marchenko M","year":"2021","unstructured":"Marchenko M, Nefedova V, Artemova N, Kleymenov S, Levitsky D, Matyushenko A. Structural and functional peculiarities of cytoplasmic tropomyosin isoforms, the products of TPM1 and TPM4 genes. Int J Mol Sci. 2021, 22:5141. 10.3390\/ijms22105141","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104484","article-title":"Distinct actin-tropomyosin cofilament populations drive the functional diversification of cytoskeletal myosin motor complexes","volume":"25","author":"Reindl T","year":"2022","unstructured":"Reindl T, Giese S, Greve JN, et al.. Distinct actin-tropomyosin cofilament populations drive the functional diversification of cytoskeletal myosin motor complexes. iScience. 2022, 25:104484. 10.1016\/j.isci.2022.104484","journal-title":"iScience"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24236","article-title":"Functional structure of the promoter regions for the predominant low molecular weight isoforms of tropomyosin in human kidney cells","volume":"113","author":"Savill SA","year":"2012","unstructured":"Savill SA, Leitch HF, Harvey JN, Thomas TH. Functional structure of the promoter regions for the predominant low molecular weight isoforms of tropomyosin in human kidney cells. J Cell Biochem. 2012, 113:3576-86. 10.1002\/jcb.24236","journal-title":"J Cell Biochem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4161\/bioa.1.4.17897","article-title":"Tropomyosin isoforms and reagents","volume":"1","author":"Schevzov G","year":"2011","unstructured":"Schevzov G, Whittaker SP, Fath T, Lin JJ, Gunning PW. Tropomyosin isoforms and reagents. Bioarchitecture. 2011, 1:135-64. 10.4161\/bioa.1.4.17897","journal-title":"Bioarchitecture"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20151","article-title":"Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder","volume":"110","author":"Pawlak G","year":"2004","unstructured":"Pawlak G, McGarvey TW, Nguyen TB, Tomaszewski JE, Puthiyaveettil R, Malkowicz SB, Helfman DM. Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer. 2004, 110:368-73. 10.1002\/ijc.20151","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002047.11","article-title":"PD37-11 tropomyosin isoform switching in urothelial bladder cancer as a diagnostic biomarker","volume":"206","author":"Humayun-Zakaria N","year":"2021","unstructured":"Humayun-Zakaria N, Ward D, Abbotts B, et al.. PD37-11 tropomyosin isoform switching in urothelial bladder cancer as a diagnostic biomarker. J Urol. 2021, 206:e659-60. 10.1097\/JU.0000000000002047.11","journal-title":"J Urol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2004.05.015","article-title":"Splice variants as cancer biomarkers","volume":"37","author":"Brinkman BM","year":"2004","unstructured":"Brinkman BM. Splice variants as cancer biomarkers. Clin Biochem. 2004, 37:584-94. 10.1016\/j.clinbiochem.2004.05.015","journal-title":"Clin Biochem"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.110056","article-title":"A personalized approach to cancer treatment: how biomarkers can help","volume":"54","author":"Duffy MJ","year":"2008","unstructured":"Duffy MJ, Crown J. A personalized approach to cancer treatment: how biomarkers can help. Clin Chem. 2008, 54:1770-9. 10.1373\/clinchem.2008.110056","journal-title":"Clin Chem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2012.02727.x","article-title":"Better cancer biomarker discovery through better study design","volume":"42","author":"Rundle A","year":"2012","unstructured":"Rundle A, Ahsan H, Vineis P. Better cancer biomarker discovery through better study design. Eur J Clin Invest. 2012, 42:1350-9. 10.1111\/j.1365-2362.2012.02727.x","journal-title":"Eur J Clin Invest"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00857-08","article-title":"Tropomyosin isoform expression regulates the transition of adhesions to determine cell speed and direction","volume":"29","author":"Bach CT","year":"2009","unstructured":"Bach CT, Creed S, Zhong J, et al.. Tropomyosin isoform expression regulates the transition of adhesions to determine cell speed and direction. Mol Cell Biol. 2009, 29:1506-14. 10.1128\/MCB.00857-08","journal-title":"Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01267-9","article-title":"Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer","volume":"31","author":"Xu T","year":"2024","unstructured":"Xu T, Verhagen MP, Teeuwssen M, et al.. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer. Cell Death Differ. 2024, 31:360-77. 10.1038\/s41418-024-01267-9","journal-title":"Cell Death Differ"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4453","article-title":"The prognostic value of TPM1-4 in hepatocellular carcinoma","volume":"11","author":"Tian Z","year":"2022","unstructured":"Tian Z, Zhao J, Wang Y. The prognostic value of TPM1-4 in hepatocellular carcinoma. Cancer Med. 2022, 11:433-46. 10.1002\/cam4.4453","journal-title":"Cancer Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189818","article-title":"The miR-133a, TPM4 and tap63\u03b3 role in myocyte differentiation microfilament remodelling and colon cancer progression","volume":"22","author":"Caporali S","year":"2021","unstructured":"Caporali S, Calabrese C, Minieri M, et al.. The miR-133a, TPM4 and tap63\u03b3 role in myocyte differentiation microfilament remodelling and colon cancer progression. Int J Mol Sci. 2021, 22:9818. 10.3390\/ijms22189818","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-49674-0_9","article-title":"Tropomyosin structure, function, and interactions: a dynamic regulator","author":"Hitchcock-DeGregori SE","year":"2017","unstructured":"Hitchcock-DeGregori SE, Barua B. Tropomyosin structure, function, and interactions: a dynamic regulator. Fibrous Proteins: Structures and Mechanisms, 1st Edition. Parry D, Squire J (ed): Springer, Cham, Switzerland; 2017. 82:253-84. 10.1007\/978-3-319-49674-0_9"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-180179","article-title":"Urinary biomarkers in the evaluation of primary hematuria: a systematic review and meta-analysis","volume":"4","author":"Sathianathen NJ","year":"2018","unstructured":"Sathianathen NJ, Butaney M, Weight CJ, Kumar R, Konety BR. Urinary biomarkers in the evaluation of primary hematuria: a systematic review and meta-analysis. Bladder Cancer. 2018, 4:353-63. 10.3233\/BLC-180179","journal-title":"Bladder Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/prca.200600609","article-title":"Expression of tropomyosin alpha 4 chain is increased in esophageal squamous cell carcinoma as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry\/mass spectrometry","volume":"1","author":"Harada T","year":"2007","unstructured":"Harada T, Kuramitsu Y, Makino A, et al.. Expression of tropomyosin alpha 4 chain is increased in esophageal squamous cell carcinoma as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry\/mass spectrometry. Proteomics Clin Appl. 2007, 1:215-23. 10.1002\/prca.200600609","journal-title":"Proteomics Clin Appl"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2217\/pme-2018-0015","article-title":"Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker","volume":"15","author":"Zare M","year":"2018","unstructured":"Zare M, Hadi F, Alivand MR. Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker. Per Med. 2018, 15:361-70. 10.2217\/pme-2018-0015","journal-title":"Per Med"},{"key":"ref37","article-title":"Actin regulation by tropomodulin and tropomyosin in neuronal morphogenesis and function","volume":"84","author":"Gray KT","year":"2017","unstructured":"Gray KT, Kostyukova AS, Fath T. Actin regulation by tropomodulin and tropomyosin in neuronal morphogenesis and function. Mol Cell Neurosci. 2017, 84:48-57.","journal-title":"Mol Cell Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13007","article-title":"Single-cell transcriptomes of mouse bladder urothelium uncover novel cell type markers and urothelial differentiation characteristics","volume":"54","author":"Li Y","year":"2021","unstructured":"Li Y, Liu Y, Gao Z, et al.. Single-cell transcriptomes of mouse bladder urothelium uncover novel cell type markers and urothelial differentiation characteristics. Cell Prolif. 2021, 54:e13007. 10.1111\/cpr.13007","journal-title":"Cell Prolif"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2015.07.001","article-title":"Targeting strategies on miRNA-21 and PDCD4 for glioblastoma","volume":"580","author":"Wang G","year":"2015","unstructured":"Wang G, Wang JJ, Tang HM, To SS. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma. Arch Biochem Biophys. 2015, 580:64-74.","journal-title":"Arch Biochem Biophys"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19182","article-title":"Tropomyosin isoform Tpm2.1 regulates collective and amoeboid cell migration and cell aggregation in breast epithelial cells","volume":"8","author":"Shin H","year":"2017","unstructured":"Shin H, Kim D, Helfman DM. Tropomyosin isoform Tpm2.1 regulates collective and amoeboid cell migration and cell aggregation in breast epithelial cells. Oncotarget. 2017, 8:95192-205. 10.18632\/oncotarget.19182","journal-title":"Oncotarget"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236040","article-title":"Alterations of chromatin regulators in the pathogenesis of urinary bladder urothelial carcinoma","volume":"13","author":"Hoffmann MJ","year":"2021","unstructured":"Hoffmann MJ, Schulz WA. Alterations of chromatin regulators in the pathogenesis of urinary bladder urothelial carcinoma. Cancers (Basel). 2021, 13:6040. 10.3390\/cancers13236040","journal-title":"Cancers (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100910","article-title":"Genomics driven precision oncology in advanced biliary tract cancer improves survival","volume":"42","author":"Kumar-Sinha C","year":"2023","unstructured":"Kumar-Sinha C, Vats P, Tran N, et al.. Genomics driven precision oncology in advanced biliary tract cancer improves survival. Neoplasia. 2023, 42:100910. 10.1016\/j.neo.2023.100910","journal-title":"Neoplasia"},{"key":"ref43","article-title":"The Role of Telomere Maintenance in Urological Malignancies","author":"Le\u00e3o RR","year":"2018","unstructured":"Le\u00e3o RR. The Role of Telomere Maintenance in Urological Malignancies. University of Coimbra, Coimbra, Portugal; 2018."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091315","article-title":"The miR-183 cluster: biogenesis, functions, and cell communication via exosomes in cancer","volume":"12","author":"Li S","year":"2023","unstructured":"Li S, Meng W, Guo Z, Liu M, He Y, Li Y, Ma Z. The miR-183 cluster: biogenesis, functions, and cell communication via exosomes in cancer. Cells. 2023, 12:1315. 10.3390\/cells12091315","journal-title":"Cells"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16825","article-title":"Loss of Tpm4.1 leads to disruption of cell-cell adhesions and invasive behavior in breast epithelial cells via increased Rac1 signaling","volume":"8","author":"Jeong S","year":"2017","unstructured":"Jeong S, Lim S, Schevzov G, Gunning PW, Helfman DM. Loss of Tpm4.1 leads to disruption of cell-cell adhesions and invasive behavior in breast epithelial cells via increased Rac1 signaling. Oncotarget. 2017, 8:33544-59. 10.18632\/oncotarget.16825","journal-title":"Oncotarget"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17714","article-title":"Insights from animal models of bladder cancer: recent advances, challenges, and opportunities","volume":"8","author":"John BA","year":"2017","unstructured":"John BA, Said N. Insights from animal models of bladder cancer: recent advances, challenges, and opportunities. Oncotarget. 2017, 8:57766-81. 10.18632\/oncotarget.17714","journal-title":"Oncotarget"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1254","article-title":"Novel mouse models of bladder cancer identify a prognostic signature associated with risk of disease progression","volume":"81","author":"Park S","year":"2021","unstructured":"Park S, Rong L, Owczarek TB, et al.. Novel mouse models of bladder cancer identify a prognostic signature associated with risk of disease progression. Cancer Res. 2021, 81:5161-75. 10.1158\/0008-5472.CAN-21-1254","journal-title":"Cancer Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-04-0353","article-title":"A critical role of tropomyosins in TGF-\u03b2 regulation of the actin cytoskeleton and cell motility in epithelial cells","volume":"15","author":"Bakin AV","year":"2004","unstructured":"Bakin AV, Safina A, Rinehart C, Daroqui C, Darbary H, Helfman DM. A critical role of tropomyosins in TGF-\u03b2 regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell. 2004, 15:4682-94. 10.1091\/mbc.e04-04-0353","journal-title":"Mol Biol Cell"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.26190\/unsworks\/18312","article-title":"Tropomyosin Isoform Specific Regulation of Cell Proliferation","author":"Wang B","year":"2015","unstructured":"Wang B. Tropomyosin Isoform Specific Regulation of Cell Proliferation. University of New South Wales, Sydney, AU; 2015. 10.26190\/unsworks\/18312"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2018.1480279","article-title":"Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1","volume":"19","author":"Liu G","year":"2018","unstructured":"Liu G, Zhao X, Zhou J, Cheng X, Ye Z, Ji Z. Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1. Cancer Biol Ther. 2018, 19:1039-56. 10.1080\/15384047.2018.1480279","journal-title":"Cancer Biol Ther"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101093","article-title":"TPM4 overexpression drives colon epithelial cell tumorigenesis by suppressing differentiation and promoting proliferation","volume":"59","author":"Macwan RS","year":"2025","unstructured":"Macwan RS, Ferrero G, Pardini B, Naccarati A, Kozlowski PB, Papetti MJ. TPM4 overexpression drives colon epithelial cell tumorigenesis by suppressing differentiation and promoting proliferation. Neoplasia. 2025, 59:101093. 10.1016\/j.neo.2024.101093","journal-title":"Neoplasia"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12399","article-title":"Tropomyosin-mediated regulation of cytoplasmic myosins","volume":"17","author":"Manstein DJ","year":"2016","unstructured":"Manstein DJ, Mulvihill DP. Tropomyosin-mediated regulation of cytoplasmic myosins. Traffic. 2016, 17:872-7. 10.1111\/tra.12399","journal-title":"Traffic"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091717","article-title":"Applications of urinary extracellular vesicles in the diagnosis and active surveillance of prostate cancer","volume":"16","author":"Smith SF","year":"2024","unstructured":"Smith SF, Brewer DS, Hurst R, Cooper CS. Applications of urinary extracellular vesicles in the diagnosis and active surveillance of prostate cancer. Cancers (Basel). 2024, 16:1717. 10.3390\/cancers16091717","journal-title":"Cancers (Basel)"},{"key":"ref54","article-title":"A Review of the Role of the Urinary Metabolome and the Impact of the Pre-analytical Phase on Urinary Biomarkers, and the Effects of Storage Duration, Storage Temperature, and Deproteinization Status on Urinary Amino Acids in Canines: A Stability Study","author":"Di Bernardo CC","year":"2020","unstructured":"Di Bernardo CC. A Review of the Role of the Urinary Metabolome and the Impact of the Pre-analytical Phase on Urinary Biomarkers, and the Effects of Storage Duration, Storage Temperature, and Deproteinization Status on Urinary Amino Acids in Canines: A Stability Study. University of California, Davis, Davis,CA; 2020."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/ctd2.176","article-title":"Urine-based liquid biopsy in bladder cancer: opportunities and challenges","volume":"3","author":"Wang G","year":"2023","unstructured":"Wang G, Jin W, Xu Z, et al.. Urine-based liquid biopsy in bladder cancer: opportunities and challenges. Clin Transl Discov. 2023, 3:e176. 10.1002\/ctd2.176","journal-title":"Clin Transl Discov"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001450","article-title":"Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation","volume":"10","author":"Kalra H","year":"2012","unstructured":"Kalra H, Simpson RJ, Ji H, et al.. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012, 10:e1001450. 10.1371\/journal.pbio.1001450","journal-title":"PLoS Biol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071529","article-title":"Urinary extracellular vesicles as potential biomarkers for urologic cancers: an overview of current methods and advances","volume":"13","author":"Louren\u00e7o C","year":"2021","unstructured":"Louren\u00e7o C, Const\u00e2ncio V, Henrique R, Carvalho \u00c2, Jer\u00f3nimo C. Urinary extracellular vesicles as potential biomarkers for urologic cancers: an overview of current methods and advances. Cancers (Basel). 2021, 13:1529. 10.3390\/cancers13071529","journal-title":"Cancers (Basel)"},{"key":"ref58","article-title":"The Properties and Function of Tropomyosin Dimers in Muscle Regulation","author":"Mackenzie C","year":"2017","unstructured":"Mackenzie C. The Properties and Function of Tropomyosin Dimers in Muscle Regulation. University of Kent, Canterbury, England; 2017."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10020066","article-title":"Identification of key biomarkers in bladder cancer: evidence from a bioinformatics analysis","volume":"10","author":"Zhang C","year":"2020","unstructured":"Zhang C, Berndt-Paetz M, Neuhaus J. Identification of key biomarkers in bladder cancer: evidence from a bioinformatics analysis. Diagnostics (Basel). 2020, 10:66. 10.3390\/diagnostics10020066","journal-title":"Diagnostics (Basel)"},{"key":"ref60","article-title":"The Role of Tropomyosins and Their Isoforms in Urothelial Carcinoma of Bladder (\u2018TropICana-B\u2019)","author":"Humayun-Zakaria N","year":"2024","unstructured":"Humayun-Zakaria N. The Role of Tropomyosins and Their Isoforms in Urothelial Carcinoma of Bladder (\u2018TropICana-B\u2019). University of Birmingham, Birmingham, England; 2024."},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/luts.12351","article-title":"Deficits of urothelial cell proliferation, cytoskeleton, and barrier function protein expressions in patients with recurrent and persistent urinary tract infections","volume":"13","author":"Jhang JF","year":"2021","unstructured":"Jhang JF, Lin TY, Ho HC, Jiang YH, Hsu YH, Birder LA, Kuo HC. Deficits of urothelial cell proliferation, cytoskeleton, and barrier function protein expressions in patients with recurrent and persistent urinary tract infections. Low Urin Tract Symptoms. 2021, 13:203-9. 10.1111\/luts.12351","journal-title":"Low Urin Tract Symptoms"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061435","article-title":"Gene expression-based functional differences between the bladder body and trigonal urothelium in adolescent female patients with micturition dysfunction","volume":"10","author":"Zeber-Lubecka N","year":"2022","unstructured":"Zeber-Lubecka N, Kulecka M, Za\u0142\u0119ska-Oracka K, et al.. Gene expression-based functional differences between the bladder body and trigonal urothelium in adolescent female patients with micturition dysfunction. Biomedicines. 2022, 10:1435. 10.3390\/biomedicines10061435","journal-title":"Biomedicines"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-023-00773-8","article-title":"Urine biomarkers in bladder cancer\u2014current status and future perspectives","volume":"20","author":"Maas M","year":"2023","unstructured":"Maas M, Todenh\u00f6fer T, Black PC. Urine biomarkers in bladder cancer\u2014current status and future perspectives. Nat Rev Urol. 2023, 20:597-614. 10.1038\/s41585-023-00773-8","journal-title":"Nat Rev Urol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10664.x","article-title":"Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic","volume":"110","author":"Blick CG","year":"2012","unstructured":"Blick CG, Nazir SA, Mallett S, et al.. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic. BJU Int. 2012, 110:84-94. 10.1111\/j.1464-410X.2011.10664.x","journal-title":"BJU Int"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(05)70231-7","article-title":"Urine cytology: is it still the gold standard for screening?","volume":"27","author":"Brown FM","year":"2000","unstructured":"Brown FM. Urine cytology: is it still the gold standard for screening?. Urol Clin North Am. 2000, 27:25-37. 10.1016\/S0094-0143(05)70231-7","journal-title":"Urol Clin North Am"},{"key":"ref66","article-title":"Cystoscopy and vesicoscopy","author":"Moran PA","year":"2023","unstructured":"Moran PA, Cole J, Greenwell T. Cystoscopy and vesicoscopy. Textbook of Female Urology and Urogynecology, 5th Edition. Cardozo L, Staskin D (ed): CRC Press, Boca Raton, FL; 2023. 373-86."},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-82048-0_10","article-title":"Urinary biomarkers: current status and future opportunities","author":"Zambrano IA","year":"2021","unstructured":"Zambrano IA, Demzik A, Bjurlin MA. Urinary biomarkers: current status and future opportunities. Comprehensive Diagnostic Approach to Bladder Cancer: Molecular Imaging and Biomarkers. Bjurlin MA, Matulewicz RS (ed): Springer, Cham, Switzerland; 2021. 163-92. 10.1007\/978-3-030-82048-0_10"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-12-23","article-title":"Influencing factors on the NMP-22 urine assay: an experimental model","volume":"12","author":"Miyake M","year":"2012","unstructured":"Miyake M, Goodison S, Giacoia EG, Rizwani W, Ross S, Rosser CJ. Influencing factors on the NMP-22 urine assay: an experimental model. BMC Urol. 2012, 12:23. 10.1186\/1471-2490-12-23","journal-title":"BMC Urol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23239","article-title":"The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer\u2014institutional experience and review","volume":"43","author":"\u00d6nal B","year":"2015","unstructured":"\u00d6nal B, Han \u00dc, Yilmaz S, K\u00f6ybasioglu F, Altu\u011f U. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer\u2014institutional experience and review. Diagn Cytopathol. 2015, 43:307-14. 10.1002\/dc.23239","journal-title":"Diagn Cytopathol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215423","article-title":"UroVysion(TM) fluorescence in situ hybridization in urological cancers: a narrative review and future perspectives","volume":"14","author":"Ke C","year":"2022","unstructured":"Ke C, Hu Z, Yang C. UroVysion(TM) fluorescence in situ hybridization in urological cancers: a narrative review and future perspectives. Cancers (Basel). 2022, 14:5423. 10.3390\/cancers14215423","journal-title":"Cancers (Basel)"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-020-09305-7","article-title":"Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management","volume":"17","author":"Tonry C","year":"2020","unstructured":"Tonry C, Finn S, Armstrong J, Pennington SR. Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management. Clin Proteomics. 2020, 17:41. 10.1186\/s12014-020-09305-7","journal-title":"Clin Proteomics"},{"key":"ref72","article-title":"Tropomyosin crystal structure and muscle regulation","volume":"192","author":"Phillips GN Jr","year":"1986","unstructured":"Phillips GN Jr, Fillers JP, Cohen C. Tropomyosin crystal structure and muscle regulation. J Mol Biol. 1986, 192:111-31.","journal-title":"J Mol Biol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-90186-4.00060-2","article-title":"Regulatory considerations for new drugs and devices","author":"Chen K","year":"2025","unstructured":"Chen K, Lim TP, Yuen JS, Ho H, Murphy DG. Regulatory considerations for new drugs and devices. Translational Urology: A volume in Handbook for Designing and Conducting Clinical and Translational Research. Eltorai AE, Arab A, Atala A, Siddiqui MM (ed): Academic Press, Cambridge, MA; 2025. 293-9. 10.1016\/B978-0-323-90186-4.00060-2"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R600004-MCP200","article-title":"Discovery of urinary biomarkers","volume":"5","author":"Pisitkun T","year":"2006","unstructured":"Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics. 2006, 5:1760-71. 10.1074\/mcp.R600004-MCP200","journal-title":"Mol Cell Proteomics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397802-tropomyosin-isoforms-as-biomarkers-for-urothelial-bladder-cancer-promise-and-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:26:39Z","timestamp":1754918799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397802-tropomyosin-isoforms-as-biomarkers-for-urothelial-bladder-cancer-promise-and-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":74,"URL":"https:\/\/doi.org\/10.7759\/cureus.89801","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}